Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

120 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Development of the alopecia areata scale for clinical use: Results of an academic-industry collaborative effort.
King BA, Mesinkovska NA, Craiglow B, Kindred C, Ko J, McMichael A, Shapiro J, Goh C, Mirmirani P, Tosti A, Hordinsky M, Huang KP, Castelo-Soccio L, Bergfeld W, Paller AS, Mackay-Wiggan J, Glashofer M, Aguh C, Piliang M, Yazdan P, Lo Sicco K, Cassella JV, Koenigsberg J, Ahluwalia G, Ghorayeb E, Fakharzadeh S, Napatalung L, Gandhi K, DeLozier AM, Nunes FP, Senna MM. King BA, et al. Among authors: senna mm. J Am Acad Dermatol. 2022 Feb;86(2):359-364. doi: 10.1016/j.jaad.2021.08.043. Epub 2021 Aug 30. J Am Acad Dermatol. 2022. PMID: 34474079 Free article.
Predictors of QOL in Patients with Alopecia Areata.
Senna M, Ko J, Glashofer M, Walker C, Ball S, Edson-Heredia E, Zhu B, Shapiro J. Senna M, et al. J Invest Dermatol. 2022 Oct;142(10):2646-2650.e3. doi: 10.1016/j.jid.2022.02.019. Epub 2022 Mar 22. J Invest Dermatol. 2022. PMID: 35331716 Free article.
Two Phase 3 Trials of Baricitinib for Alopecia Areata.
King B, Ohyama M, Kwon O, Zlotogorski A, Ko J, Mesinkovska NA, Hordinsky M, Dutronc Y, Wu WS, McCollam J, Chiasserini C, Yu G, Stanley S, Holzwarth K, DeLozier AM, Sinclair R; BRAVE-AA Investigators. King B, et al. N Engl J Med. 2022 May 5;386(18):1687-1699. doi: 10.1056/NEJMoa2110343. Epub 2022 Mar 26. N Engl J Med. 2022. PMID: 35334197 Clinical Trial.
Efficacy and Safety of Baricitinib in Patients with Severe Alopecia Areata over 52 Weeks of Continuous Therapy in Two Phase III Trials (BRAVE-AA1 and BRAVE-AA2).
Kwon O, Senna MM, Sinclair R, Ito T, Dutronc Y, Lin CY, Yu G, Chiasserini C, McCollam J, Wu WS, King B. Kwon O, et al. Among authors: senna mm. Am J Clin Dermatol. 2023 May;24(3):443-451. doi: 10.1007/s40257-023-00764-w. Epub 2023 Mar 1. Am J Clin Dermatol. 2023. PMID: 36855020 Free PMC article. Clinical Trial.
Shared Genetic Risk Variants in Both Male and Female Frontal Fibrosing Alopecia.
Rayinda T, McSweeney SM, Fenton D, Stefanato CM, Harries M, Palamaras I, Tidman A, Holmes S, Koutalopoulou A, Ardern-Jones M, Williams G, Papanikou S, Chasapi V, Vañó-Galvan S, Saceda-Corralo D, Melián-Olivera A, Azcarraga-Llobet C, Lobato-Berezo A, Bustamante M, Sunyer J, Starace MVR, Piraccini BM, Wiss IP, Senna MM, Singh R, Hilmann K, Kanti-Schmidt V, Blume-Peytavi U, Simpson M, McGrath JA, Dand N, Tziotzios C. Rayinda T, et al. Among authors: senna mm. J Invest Dermatol. 2023 Nov;143(11):2311-2314.e5. doi: 10.1016/j.jid.2023.04.022. Epub 2023 May 19. J Invest Dermatol. 2023. PMID: 37211199 Free article. No abstract available.
120 results